Search
MDX-214
go.drugbank.com/drugs/DB06110ExperimentalIt is developed for the treatment of EGF-R overexpressing cancers.
Quisqualic acid
go.drugbank.com/drugs/DB02999ExperimentalQuisqualic acid is an agonist at two subsets of excitatory amino acid receptors, ionotropic receptors that directly control membrane channels and metabotropic receptors that indirectly mediate calcium
Olenasufligene relduparvovec
go.drugbank.com/drugs/DB16264InvestigationalIt is an adeno-associated virus (AAV) vector that delivers a functional copy of the human SGSH gene.[L46671]
VTX-801
go.drugbank.com/drugs/DB17646InvestigationalIt is being investigated in Wilson Disease.[L45924]
RP-A501
go.drugbank.com/drugs/DB17647InvestigationalIt is being investigated for Danon disease.[L45934]
Citatuzumab Bogatox
go.drugbank.com/drugs/DB06072InvestigationalVB6-845 has demonstrated effective cancer cell killing properties in pre-clinical tests.
Picafibrate
go.drugbank.com/drugs/DB19574ExperimentalPicafibrate has a monoisotopic molecular weight of 362.1 Da.
Tiafibrate
go.drugbank.com/drugs/DB19874ExperimentalTiafibrate has a monoisotopic molecular weight of 686.23 Da.
Iolopride I-123
go.drugbank.com/drugs/DB20028ExperimentalIolopride I-123 has a monoisotopic molecular weight of 400.06 Da.
Urefibrate
go.drugbank.com/drugs/DB20849ExperimentalUrefibrate has a monoisotopic molecular weight of 354.02 Da.